Related Experiment Video
Updated: Feb 21, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
The impact of gallic acid on the methotrexate-induced kidney damage in rats
Halil Asci1, Ozlem Ozmen2, Hamit Yasar Ellidag3
1Department of Pharmacology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
Abstract:
Prolonged use of an antineoplastic agent methotrexate (MTX), can cause numerous side effects such as nephrotoxicity. The aim of this study was to examine the effects of MTX on kidneys and demonstrate the protective effects of gallic acid (GA). Twenty-four, male, rats distributed into three groups. Each groups consisted eight rats and only saline was administered to the control group. The MTX group received a single dose (20 mg/kg) MTX intraperitoneally. The MTX + GA group received same dose MTX and 100 mg/kg GA orally during the 7 days. Renal functions, oxidative stress markers, histopathological and immunohistochemical changes were evaluated at the end of the experiment. Blood urea nitrogen, creatinine, uric acid levels and tissue oxidative stress markers, total oxidant status and oxidative stress index levels significantly increased and total antioxidant status levels significantly decreased in MTX group compared with the control group. At the histopathological examination hemorrhages, tubular cell necrosis, glomerulosclerosis, inflammatory cell infiltrations and proteinous materials in tubules were noticed in MTX group. Immunohistochemical examination revealed that increased expressions of serum amyloid A (SAA), tumor necrosis factor alpha (TNF-α), prostaglandin E2 (PGE-2) and C-reactive protein (CRP) in tubular epithelial cells of kidneys in this group. There were no immunoreaction with SAA and CRP, only small number of PGE-2 and TNF-α positive tubular epithelial cells were observed in MTX + GA group. In conclusion, all evidence suggested that oxidative stress caused MTX-induced nephrotoxicity and GA prevent the kidney from the nephrotoxicity due to its antioxidant and anti-inflammatory activities.
Insights
Methotrexate (MTX) causes kidney damage through oxidative stress. Gallic acid (GA) protects against MTX-induced nephrotoxicity by reducing oxidative stress and inflammation.
Area of Science:
- Toxicology
- Pharmacology
- Nephrology
Background:
- Antineoplastic agents like methotrexate (MTX) can cause significant side effects.
- Nephrotoxicity is a serious concern associated with prolonged MTX use.
Purpose of the Study:
- To investigate the kidney damage induced by MTX.
- To evaluate the protective effects of gallic acid (GA) against MTX-induced nephrotoxicity.
Main Methods:
- Male rats were divided into three groups: control, MTX-treated, and MTX + GA-treated.
- Kidney function, oxidative stress markers, and histopathological changes were assessed.
- Immunohistochemical analysis was performed to evaluate specific protein expressions.
Main Results:
- MTX administration significantly increased blood urea nitrogen, creatinine, uric acid, and oxidative stress markers, while decreasing antioxidant status.
- Histopathological examination revealed tubular necrosis, glomerulosclerosis, and inflammation in the MTX group.
- MTX increased the expression of SAA, TNF-α, PGE-2, and CRP, which was significantly reduced by GA treatment.
Conclusions:
- Oxidative stress plays a key role in MTX-induced nephrotoxicity.
- Gallic acid exhibits significant protective effects against MTX-induced kidney damage due to its antioxidant and anti-inflammatory properties.
More Related Videos
10:38In Vivo Alkaline Comet Assay and Enzyme-modified Alkaline Comet Assay for Measuring DNA Strand Breaks and Oxidative DNA Damage in Rat Liver
Published on: May 4, 2016
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Drug toxicity: Drug–Drug Interaction
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...